Literature DB >> 17547862

Acute and chronic megacolon.

Stephen B Hanauer1, Arnold Wald.   

Abstract

Megacolon, defined as dilation of the abdominal colon, may occur acutely or in a chronic form. Acute megacolon that occurs in association with severe inflammation of the colon is known as toxic megacolon, whereas acute megacolon without obvious colonic disease is known as Ogilvie's syndrome. The pathophysiology and management of toxic megacolon, Ogilvie's syndrome, and chronic megacolon in adults differ significantly, and it is critically important to distinguish among these entities. Toxic megacolon is a medical emergency that requires coordinated intensive medical and surgical management. In addition to vigorous resuscitation with fluids, electrolytes, and blood products, medical treatment consists of parenteral corticosteroids, broad-spectrum antibiotics, and close monitoring of the patient. Surgical intervention is required if there is no improvement, or deterioration after 12 to 24 hours of intensive medical management, or if there is evidence of colon perforation. Ogilvie's syndrome usually occurs in hospitalized patients with serious underlying medical or surgical illnesses. Management is directed at preventing ischemia and perforation of the distended colon. Supportive therapy includes nasogastric suction, correction of fluid and electrolyte imbalances, stopping potentially aggravating medications, and decompressing the colon with a rectal tube and positional changes. Intravenous neostigmine is the only pharmacologic agent of proven efficacy; colonoscopic decompression is an alternative in patients who do not respond to neostigmine or who have conditions that contraindicate its use. Daily oral administration of polyethylene glycol electrolyte solutions appears to decrease the relapse rate after initial decompression is achieved. Chronic megacolon in adults represents advanced colon failure that does not respond to pharmacologic stimulation. Goals of therapy are to cleanse the colon, prevent impaction, and minimize stool volume and gas buildup. For patients with disabling symptoms, surgical exclusion of the colon, decompression and antegrade enemas via cecostomy, or subtotal or segmental resection may be palliative.

Entities:  

Year:  2007        PMID: 17547862     DOI: 10.1007/s11938-007-0017-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  48 in total

1.  Assessment of severity in colitis: a preliminary study.

Authors:  J E Lennard-Jones; J K Ritchie; W Hilder; C C Spicer
Journal:  Gut       Date:  1975-08       Impact factor: 23.059

Review 2.  The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research.

Authors:  Daniel W Hommes; Gerben Sterringa; Sander J H van Deventer; Guido N J Tytgat; Jan Weel
Journal:  Inflamm Bowel Dis       Date:  2004-05       Impact factor: 5.325

Review 3.  Cyclosporine for severe ulcerative colitis.

Authors:  Co Q D Pham; Carly B Efros; Rosemary R Berardi
Journal:  Ann Pharmacother       Date:  2005-12-20       Impact factor: 3.154

4.  Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon.

Authors:  Thilo Wedel; Juliane Spiegler; Stefan Soellner; Uwe J Roblick; Thomas H K Schiedeck; Hans-Peter Bruch; Heinz-Juergen Krammer
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

5.  Practice parameters for the surgical treatment of ulcerative colitis.

Authors:  Jeffrey L Cohen; Scott A Strong; Neil H Hyman; W Donald Buie; Gary D Dunn; Clifford Y Ko; Phillip R Fleshner; Thomas J Stahl; Donald G Kim; Amir L Bastawrous; W Brian Perry; Peter A Cataldo; Janice F Rafferty; C Neal Ellis; Jan Rakinic; Sharon Gregorcyk; Paul C Shellito; John W Kilkenny; Charles A Ternent; Walter Koltun; Joe J Tjandra; Charles P Orsay; Mark H Whiteford; Jason R Penzer
Journal:  Dis Colon Rectum       Date:  2005-11       Impact factor: 4.585

6.  Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection.

Authors:  G Maconi; E Colombo; P Zerbi; G M Sampietro; P Fociani; M Bosani; A Cassinotti; V Casini; A Russo; S Ardizzone; M Porta; G Bianchi Porro
Journal:  Dig Liver Dis       Date:  2005-03-16       Impact factor: 4.088

7.  Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial.

Authors:  Fabrizio Bossa; Serafina Fiorella; Nazario Caruso; Laura Accadia; Grazia Napolitano; Maria Rosa Valvano; Angelo Andriulli; Vito Annese
Journal:  Am J Gastroenterol       Date:  2007-03       Impact factor: 10.864

Review 8.  Management of acute severe colitis.

Authors:  Simon L Jakobovits; S P L Travis
Journal:  Br Med Bull       Date:  2006-07-17       Impact factor: 4.291

9.  Plain X-ray films and air enema films reflect severe mucosal inflammation in acute ulcerative colitis.

Authors:  S Almer; G Bodemar; L Franzén; E Lindström; B Norén; M Ström
Journal:  Digestion       Date:  1995       Impact factor: 3.216

10.  Early recognition of toxic megacolon.

Authors:  R Caprilli; P Vernia; G Latella; A Torsoli
Journal:  J Clin Gastroenterol       Date:  1987-04       Impact factor: 3.062

View more
  7 in total

1.  Role of brain-derived neurotrophic factor in the pathogenesis of distention-associated abdominal pain in bowel obstruction.

Authors:  Y Fu; Y M Lin; J H Winston; R Radhakrishnan; L-Y M Huang; X Z Shi
Journal:  Neurogastroenterol Motil       Date:  2018-05-21       Impact factor: 3.598

2.  Pathogenesis of abdominal pain in bowel obstruction: role of mechanical stress-induced upregulation of nerve growth factor in gut smooth muscle cells.

Authors:  You-Min Lin; Yu Fu; John Winston; Ravi Radhakrishnan; Sushil K Sarna; Li-Yen M Huang; Xuan-Zheng Shi
Journal:  Pain       Date:  2017-04       Impact factor: 7.926

3.  Mechanical stress is a pro-inflammatory stimulus in the gut: in vitro, in vivo and ex vivo evidence.

Authors:  You-Min Lin; Feng Li; Xuan-Zheng Shi
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

Review 4.  Mechanical Regulation of Gene Expression in Gut Smooth Muscle Cells.

Authors:  Xuan-Zheng Shi
Journal:  Front Physiol       Date:  2017-12-05       Impact factor: 4.566

5.  Colonic transit time and pressure based on Bernoulli's principle.

Authors:  Yoshiharu Uno
Journal:  Clin Exp Gastroenterol       Date:  2018-04-05

6.  Non-toxic Megacolon Secondary to High-Grade Large-Bowel Obstruction.

Authors:  Nathan D Mullen; Hunter Thurn; Eric Karr; Kathryn M Burtson
Journal:  Cureus       Date:  2022-01-25

7.  Novel Insights Into the Mechanisms of Abdominal Pain in Obstructive Bowel Disorders.

Authors:  Xuan-Zheng Shi; You-Min Lin; Shrilakshmi Hegde
Journal:  Front Integr Neurosci       Date:  2018-06-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.